Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findingsStefan Kubicka, Christophe Borg, Roger von Moos et al.|Annals of Oncology|2013Cited by 104
Supplementary Material for: Retrospective Analysis of CA19-9 Decrease in Patients with Metastatic Pancreatic Carcinoma Treated with FOLFIRINOX or Gemcitabine in a Randomized Phase III Study (ACCORD11/PRODIGE4)Marie Robert, Jaafar Bennouna, Marta Jarlier et al.|INDIGO (University of Illinois at Chicago)|2017Cited by 0
Supplementary Material for: Retrospective Analysis of CA19-9 Decrease in Patients with Metastatic Pancreatic Carcinoma Treated with FOLFIRINOX or Gemcitabine in a Randomized Phase III Study (ACCORD11/PRODIGE4)Marie Robert, Jaafar Bennouna, Marta Jarlier et al.|Figshare|2017Cited by 0